Special Initiative on Noncommunicable Diseases (NCDs) and Innovation, WHO Regional Office for Europe

Using conversational AI to provide scalable, personalized, and cost-effective addiction psychotherapy for healthcare orgs. Backed by CAMH, MVP launching 2025.UTEST (University of Toronto Early-Stage Technology) supports emerging deep tech entrepreneurs building research-based companies.

Run global epidemiology projects on alcohol for the WHO/PAHO Collaborating Centre for Addiction Mental Health. This includes:- surveillance projects and comparative risk assessments in 194 countries- global health estimates for a UN Sustainable Development Goal- policy recommendations and technical advise for public health teams, UN agencies, governments, and researchers internationally- modelling, systematic reviews, and publicationsAll are used for policy and… Show more Run global epidemiology projects on alcohol for the WHO/PAHO Collaborating Centre for Addiction Mental Health. This includes:- surveillance projects and comparative risk assessments in 194 countries- global health estimates for a UN Sustainable Development Goal- policy recommendations and technical advise for public health teams, UN agencies, governments, and researchers internationally- modelling, systematic reviews, and publicationsAll are used for policy and health system responses, as well as global and regional strategies to reduce the burden of disease from alcohol. Show less

We’re exploring the applications of low dose 5-MeO-DMT for mindfulness and mental health.Current projects include:- developing psycholytic therapies with clinicians- research to evaluate mindfulness, mental health, and safety outcomes- creating protocols to explore wellness applications- educational resources for the public

Noncommunicable Diseases and Mental Health department. Analyzed NCD risk factor trends across Latin America and the Caribbean. Complex survey regression modelling, data visualizations, and a report were used to inform policy responses.

Member of the WHO Global Information System on Alcohol and Health Steering Committee.

Managed the administration of grants ($5M+) for R&D and social innovation projects between industry and academic partners.

Oversaw site operations for psychiatric clinical trials, including novel treatments for Alzheimer's Disease and Depression (neurotechnologies, cognitive therapies, medications).

Supported a national evaluation of harm reduction programs for adults experiencing homelessness and alcohol use disorders.

Conducted neuropsych tests and recruitment for a neurodegenerative diseases research initiative. Focused on improving diagnostics for 5 types of dementia.